We think you have liked this presentation. If you wish to download it, please recommend it to your friends in any social system. Share buttons are a little bit lower. Thank you!
Presentation is loading. Please wait.
Published byYuliana Lesmana
Modified over 5 years ago
Long-Term Survival of Patients With pN2 Lung Cancer According to the Pattern of Lymphatic Spread Antoine Legras, MD, Pierre Mordant, MD, PhD, Alex Arame, MD, Christophe Foucault, MD, Antoine Dujon, MD, Françoise Le Pimpec Barthes, MD, PhD, Marc Riquet, MD, PhD The Annals of Thoracic Surgery Volume 97, Issue 4, Pages (April 2014) DOI: /j.athoracsur Copyright © 2014 The Society of Thoracic Surgeons Terms and Conditions
Fig 1 Schematic representation of the different patterns of lymphatic spread from the right lung: (A) pN0N2-1S; (B) pN1N2-1S; (C) pN0N2-2S; and (D) pN1N2-2S. The Annals of Thoracic Surgery , DOI: ( /j.athoracsur ) Copyright © 2014 The Society of Thoracic Surgeons Terms and Conditions
Fig 2 Long-term survival according to the cN status: cN0 (n = 238) median 30 months, 5-year 32%; cN1 (n = 96) median 19 months, 5-year 20.3%; cN2 (n = 537) median 21 months, 5-year 22.7% (p = 0.0015). The Annals of Thoracic Surgery , DOI: ( /j.athoracsur ) Copyright © 2014 The Society of Thoracic Surgeons Terms and Conditions
Fig 3 Long-term survival according to the pN status and the type of pN2 involvement. (A) Long-term survival of pN0, pN1, and pN2 patients. pN0 (n = 2,317) median 80 months, 5-year 58.6%, 10-year 37.3%. pN1 (n = 722) median 48 months, 5-year 45.1%, 10-year 26.8%. pN2 (n = 871) median 23 months, 5-year 25.4%, 10-year 17% (p < 0.001). (B) Long-term survival of pN2-1S and pN2-2S. pN2-1S (n = 575) median 26 months, 5-year 29.8%, 10-year 20.6%. pN2-2S (n = 296) median 16 months, 5-year 16.8%, 10-year 9.7% (p < 0.001). (C) Long-term survival of pN0N2-1S, pN0N2-2S, pN1N2-1S, pN1N2-2S patients (p < 0.001). The Annals of Thoracic Surgery , DOI: ( /j.athoracsur ) Copyright © 2014 The Society of Thoracic Surgeons Terms and Conditions
Jeffrey M. Griffin, MD, MS, Carolyn E. Reed, MD, Chadrick E
Number of Mediastinal Lymph Nodes in Non-Small Cell Lung Cancer: A Gaussian Curve, Not a Prognostic Factor Marc Riquet, MD, PhD, Antoine Legras, MD,
Complete Thoracic Mediastinal Lymphadenectomy Leads to a Higher Rate of Pathologically Proven N2 Disease in Patients With Non-Small Cell Lung Cancer
History of Multiple Previous Malignancies Should Not Be a Contraindication to the Surgical Resection of Lung Cancer Pierre-Benoit Pagès, MD, Pierre Mordant,
Bronchial Carcinoid Tumors Causing Cushing's Syndrome: More Aggressive Behavior and the Need for Early Diagnosis Guillaume Boddaert, MD, Bertrand Grand,
Video-Assisted Thoracoscopic Lobectomy for Lung Cancer: Current Practice Patterns and Predictors of Adoption Justin D. Blasberg, MD, Christopher W. Seder,
Constantin Stefanidis, MD, Albert M
Is the Rate of Pneumonectomy Higher in Right Middle Lobe Lung Cancer Than in Other Right-Sided Locations? Caroline Rivera, MD, Pierre Mordant, MD, PhD,
Lisa M. Brown, MD, MAS, David T. Cooke, MD, Elizabeth A. David, MD
Prognostic Factors Associated With Interventional Bronchoscopy in Lung Cancer Nicolas Guibert, MD, Julien Mazieres, MD, PhD, Benoît Lepage, MD, Gavin.
Benjamin E. Lee, MD, Mark Shapiro, MD, John R. Rutledge, MAS, Robert J
The Annals of Thoracic Surgery
Video-Assisted Thoracic Surgery Lobectomy: Experience With 1,100 Cases
Postoperative Pneumonia After Major Pulmonary Resections: An Unsolved Problem in Thoracic Surgery Dana M. Radu, MD, Françoise Jauréguy, Pharm D, Agathe.
Operative Results and Outcomes in Children With Shone's Anomaly
Prognostic Predictors in Non-Small Cell Lung Cancer Patients Undergoing Intentional Segmentectomy Terumoto Koike, MD, PhD, Teruaki Koike, MD, PhD, Yasushi.
Michelle C. Ellis, MD, Brian S. Diggs, PhD, John T. Vetto, MD, Paul H
Philip W. Smith, MD, Hongkun Wang, PhD, Leo M. Gazoni, MD, K
Eduardo Crema, PhD, MD, Lara B. P. Ribeiro, Juverson A. Terra, Alex A
© 2023 SlidePlayer.com Inc. All rights reserved.